The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea

February 26, 2019 updated by: Arie Oksenberg, Loewenstein Hospital

The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea - Towards Enhanced And Individualized Estimation Of OSA Severity

Obstructive sleep apnea (OSA) is a common nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep. Currently, clinical diagnosis of OSA is based on the clinical symptoms, especially excessive daytime sleepiness, and apnea-hypopnea index (AHI) providing a limited overview of the breathing cessation event frequency during the night. Longer obstruction events and deeper desaturations have been suggested to be more harmful than shorter and shallower events and these individual characteristics are completely neglected by conventional and currently used AHI.

The investigators have previously introduced novel diagnostic parameters incorporating the number, duration and morphology of individual obstruction events and shown that they improve the severity estimation of OSA compared to traditional measures. Even though, the novel diagnostic parameters have so far tackled some of shortcomings of AHI, they need to be refined to further increase the accuracy of the OSA severity estimation.

It has been shown that age, body mass index (BMI) and sleeping position are strongly related to the severity OSA. However, it is not thoroughly studied whether the severity of individual obstruction events progress over time (the aging process) and which factors affect to this progression. It is known that OSA patients with similar AHI values, durations of individual breathing cessation events can differ significantly. Longer and deeper events are connected to increased mortality rate in patients with moderate or severe OSA and thus, could be considered to be more detrimental than shorter and shallower ones. However, it has not been thoroughly investigated whether in severe OSA patients with identical AHI values, sleep efficiency or hypertension is related to the severity of individual breathing cessation events.

The investigators planned to explore, whether the individual breathing cessation event severity progress over time and how different confounding factors affect this progression. Furthermore, the correlation of EDS with the individual breathing cessation event severity, sleep structure, and frequency and occurrence of cortical arousals will be investigated. Also, the investigators will explore whether the percentage time of disturbed breathing from total sleep time is related to sleep efficiency or hypertension in severe OSA patients having similar AHI. Moreover, Positional therapy (PT) i.e., the avoidance of the supine posture during sleep is the treatment of choice for Positional Patients (PP) having most of their breathing abnormalities while sleeping supine. Since it is known that apneas/hypopneas are more severe while sleeping supine, this time the investigators will assess the therapeutic value of PT for severe Non Positional patients (NPP).

Study Overview

Status

Unknown

Detailed Description

Obstructive sleep apnea (OSA) is a prevalent nocturnal breathing disorder characterized by complete (apnea) and partial (hypopnea) breathing cessations during sleep 1. OSA is connected to cardiovascular disease, increased mortality rate and impairment of quality of life 2-4. Its prevalence has been estimated to be 9-27 % among middle-aged population and the prevalence is expected to increase in the future 5,6.

Currently, the most commonly used diagnostic parameter for OSA is apnea-hypopnea index (AHI) based on number of apneas and hypopneas during sleep, neglecting their durations and also durations and depths of related desaturation events. In adults OSA is diagnosed if patient has 1) AHI≥5 events/h with associated symptoms (e.g. excessive daytime sleepiness (EDS)) or medical or psychiatric disorder (e.g. hypertension or mood disorder) or 2) AHI≥15 events/h 7.

Previously, the investigators have introduced novel parameters called as obstruction severity, obstruction duration, desaturation severity, desaturation duration, and adjusted-AHI incorporating number, duration and morphology of individual obstruction events (i.e. apneas, hypopneas, and oxygen desaturations) 8,9.we have shown that these parameters can enhance the severity estimation of OSA and that the individual breathing cessation event severity is more strongly connected to increased mortality and cardiovascular morbidities than conventional AHI8,10,11. The potential of these parameters to enhance the assessment of severity of OSA has been previously investigated only using ambulatory polygraphic recordings without EEG registration. Therefore, the parameters do not take into account hypopneas followed by arousal (but not desaturation). In addition, parameters do not take into account apneas not followed by desaturation and novel parameters need to be refined to take into account also such events in order to further increase their prognostic value.

It is known that age and body mass index (BMI) are positively related with the prevalence of OSA12,13. Furthermore, AHI is higher and apneas longer in supine position compared to lateral position14-16. However, it is not thoroughly explored whether the severity of individual obstruction events progress over time and which factors affect to this progression.

EDS is a common symptom of OSA and it can be measured in various methods. The most widely used methods are Epworth Sleepiness Scale (ESS) questionnaire which measures subjective sleepiness and Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT) which measure sleepiness objectively. However, the correlation between ESS score and the severity of OSA (i.e. number of obstruction events) have been shown to be poor 17. Furthermore, albeit MSLT and MWT have been shown to have better correlations with daytime functions than ESS their correlations with AHI and arousal index still remainsweak18. Therefore, it needs to be investigated whether the severity of individual breathing cessation events is correlated better with MSLT and MWT and thus, explaining with more accuracy the daytime symptoms.

It has been shown that between patients with identical AHI values, durations of individual apneas and hypopneas and durations, depths, and areas of individual desaturations can differ significantly 19. Longer and deeper obstruction events could be considered to be more harmful than shorter and shallower events as they are linked to increased mortality rate in patients with moderate or severe OSA 8. Nonetheless, it has not been thoroughly investigated whether in severe OSA patients with identical AHI values sleep efficiency or hypertension is related to the severity of individual breathing cessation events and if this relationship is modulated by sleeping position.

Positional therapy (PT), the avoidance of the supine posture during sleep is the treatment of choice for Positional Patients (PP) who have only or most of the apneas/hypopneas while sleeping in the supine posture 22. Non positional patients (NPP) have many apneas/hypopneas while sleeping in both, the supine and the lateral posture. For these patients Continuous Positive Airway Pressure (CPAP) is the treatment of choice, however, many patients have strong difficulties to adhere to CPAP and thus, the investigators would like to assess the therapeutic value of PT for these NNP. Since apneas/hypopneas are more severe while sleeping in the supine than in the lateral posture.15, 16 PT for these patients could represent a valuable treatment. This is an issue that the investigators also want to assess in this project.

In this research project the investigators aim to tackle these shortcomings in the diagnostics of OSA. The main aim is to improve the severity estimation of OSA by further refining the novel parameters for diagnostics of OSA. These improvements to the parameters will be done in order to prevent the harmful consequences of the disease and to be able to target the limited treatment resources to those in the greatest need.

2. HYPOTHESES AND AIMS

In this research project the investigators tackle the limitations of AHI and refine the novel parameters introduced in our earlier papers. To achieve this, four aims will be undertaken. The first aim is to explore, whether the severity of individual breathing cessations progresses over time and how different confounding factors (e.g. BMI, sleeping position, and gender) affect this progression. The investigators believe that individual event characteristics have a major role in the overall severity of OSA. The current knowledge on the progression of OSA is limited to number of events while the detailed changes in the individual event characteristics has not been thoroughly explored before. This is a major shortcoming as event severity can be considered clinically significant and have been associated with the risk of OSA related mortality and cardiovascular morbidity. The second aim is to improve our recently developed novel parameters to provide even more accurate severity estimation by including more detailed analysis of hypopnea events followed by arousal and apnea events that do not induce desaturations. This more detailed analysis can enhance the estimation of OSA related mortality and incidence of comorbidities and improve the discrimination of patients needed to be treated but it can also help clinicians to choose best individualized treatment method for each patient. The third aim of the research project is to evaluate the correlation of excessive daytime sleepiness (EDS) with the individual breathing cessation event severity, sleep structure, and frequency and occurrence of cortical arousals. As EDS is a major problem reducing the quality of life, finding effective measures to recognize factors behind EDS could aid to enhance the treatment of these patients and improvement of their life quality. The fourth aim is to explore whether the percentage time of disturbed breathing from total sleep time is related to sleep efficiency or hypertension in severe OSA patients having similar AHI values and whether this percentage alters depending on confounding factors (e.g. BMI, hypertension, and proportion of supine sleep). More detailed characterization of severe OSA patients could aid the clinicians to recognize the patients with most urgent need for effective treatment.

The fifth aim is to assess the therapeutic value of positional therapy (PT) for severe NPP. This assessment is of interest since many severe OSA patients that should be treated with CPAP are not been treated due to the difficulties to adhere to CPAP treatment. This behavioral treatment could represent a partial solution until these patients lose weight, consider surgery (ENT or bariatric) or the use of dental appliance or give to CPAP another chance.

It is important to note that by losing weight NPP may become PP 23 and thus, PT could represent no a partial but a more radical solution.

2. RESEARCH PLAN AND METHODS

The planned research includes five work packages designed to enable reaching the project aims.

Work package I: Progression of individual obstruction events over time - retrospective follow-up study In this package,we will explore how the duration of individual apnea and hypopnea events and duration, depth and area of individual desaturation events progress over time. It will be investigated how different confounding factors (e.g. age, BMI, sleeping position and gender) affect the progression of the individual breathing cessation event severity. This package is based on polysomnographic (PSG) recordings of about 400 patients with suspected OSA recorded with Embla (Natus Medical Incorporated, Pleasanton, CA, USA) or Rembrandt (Natus Medical Incorporated, Pleasanton, CA, USA) devices and analyzed using RemLogic software at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center, Raanana, Israel. For all patients, two - three PSG recordings were conducted at different time points, at baseline, and after 3, 5, 10 years or more. These polygraphic recordings were analyzed in conformity with the standard respiratory rules specified by AASM and based on clinical practice in Lowenstein Hospital at the time of analysis. Based on the analyzed recordings, the severity of individual obstruction events will be calculated using custom-made MATLAB (Matlab R2014b, MathWorks Inc., Natick, MA, USA) functions. Severity of individual obstruction events will be compared between the different time points for each patient and in a group level. Grouping of the patients will be done based on the confounding factors (e.g. patients' BMI, gender, sleeping position, AHI, and age).

Work package II: Optimization of the diagnostic parameters of OSA which incorporates the severity of individual breathing cessation events In this package, the novel parameters will be further refined by adding features to also include apneas not followed by desaturations and hypopneas followed by arousal (but not desaturation). Furthermore, the aim is to evaluate whether apneas should be given more weight than hypopneas while estimating the overall severity of OSA. In this package, in-laboratory PSG recordings (n=7540) including EEG conducted and analyzed at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center for the patients with clinical suspicion of OSA will be studied. The basic anthropometric data and information on mortality and co-morbidities will be also collected. All recordings were analyzed according the standard respiratory rules defined by AASM and based on clinical practice in Lowenstein Hospital. Novel parameters and severity of individual obstruction events will be calculated using custom-made MATLAB functions. The calculated severity indexes based on enhanced and the original obstruction severity parameters will be compared with incidence of OSA related mortality and co-morbidities.

The information on mortality, cause of death and co-morbidities hopefully will be obtained from the Ministry of Health.

Work package III: Effect of severity of individual obstruction events on excessive daytime sleepiness In this package, the investigators investigate the correlation between the severity of individual breathing cessation events and excessive daytime sleepiness measured with objective means (i.e. Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT)). Furthermore, it will be studied which information obtained from PSG recordings (e.g. frequency and duration of cortical arousal, sleep structure or severity of individual obstruction events) is best correlated with excessive daytime sleepiness and therefore, would be beneficial to take into account while estimating the severity of OSA. Clinical in-laboratory PSG recordings (n=3000) of patients with suspected OSA, conducted and analyzed at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center with the Embla devices and RemLogic software, will be used. The values of the novel parameters and the severity of individual obstruction events will be calculated using custom-made MATLAB functions and their correlation on results of objective tests measuring excessive daytime sleepiness (i.e. MSLT and MWT) will be investigated.

Work package IV: Differences in severity of individual obstruction events between patients having severe OSA In this package, the severe OSA patients will be matched by AHI and the percentage time of disturbed breathing from total sleep time will be compared between these patients. The patient population consists of 463 patients diagnosed to have severe OSA after full overnight PSG recording conducted at the Sleep Disorders Unit, Lowenstein Hospital - Rehabilitation Center. It will be studied whether the percentage time of disturbed breathing from total sleep time differs between the patients having similar AHI and whether it is related to different outcome measures (e.g. hypertension and sleep efficiency). Furthermore, it will be investigated whether this percentage is modulated by different confounding factors (e.g. gender, BMI, and sleeping position).

Work package V: The assessment of the therapeutic value of Positional Therapy for severe Non Positional Patients (NPP) In this package the investigators we will assess the therapeutic value of Positional Therapy (PT) i.e., the avoidance of the supine posture during sleep, as a treatment alternative for severe Non Positional Patients (NPP) who failed to adhere to Continuous Positive Airway Pressure (CPAP). The patient population consists of the same 463 patients diagnosed to have severe OSA after full overnight PSG recording conducted at the Sleep Disorders Unit, Loewenstein Hospital - Rehabilitation Center. In this group of patients the investigators will assess the effect of sleeping only in the lateral posture (PT) and the assessment of the severity of the disease will be calculated according to conventional and new methods developed previously by our research group.

Study Type

Observational

Enrollment (Anticipated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Brisbane, Australia
        • Enrolling by invitation
        • Sleep Disorders Centre, Department of Respiratory & Sleep Medicine, Princess Alexandra Hospital, Australia
      • Kuopio, Finland
        • Enrolling by invitation
        • Department of Applied Physics, University of Eastern Finland
      • Seinäjoki, Finland
        • Enrolling by invitation
        • Department of Clinical Neurophysiology, Seinäjoki Central Hospital,
      • Ra'anana, Israel, 43100
        • Recruiting
        • Sleep Disorders Unit - Loewenstein Hospital
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 95 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

In-laboratory PSG recordings (n=7540) including EEG conducted and analysed at the Sleep Disorders Unit, Loewenstein Hospital - Rehabilitation Center for the patients with clinical suspicion of OSA will be studied.

Description

Inclusion Criteria:

  • Good technical quality of polysomnographic (PSG) records

Exclusion Criteria:

  • Bad technical quality of polysomnographic (PSG) records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of individual obstruction events over time.
Time Frame: From the beginning until December 2019
We will explore how the duration of individual apnea and hypopnea events and duration, depth and area of individual desaturation events progress over time.
From the beginning until December 2019
Optimization of OSA severity definition.
Time Frame: January 2018 until December 2020
Optimization of the diagnostic parameters of OSA which incorporates the severity of individual breathing cessation events.
January 2018 until December 2020
Effect of severity of individual obstruction events on excessive daytime sleepiness.
Time Frame: January 2018 until December 2019
We will investigate the correlation between the severity of individual breathing cessation events and excessive daytime sleepiness measured with objective means (i.e. Multiple Sleep Latency Test (MSLT) and Maintenance of Wakefulness Test (MWT))
January 2018 until December 2019
Differences in severity of individual obstruction events between patients having severe OSA according to AHI.
Time Frame: From the beginning until December 2018
Severe OSA patients will be matched by AHI and the percentage time of disturbed breathing from total sleep time will be compared between these patients.
From the beginning until December 2018
The assessment of the therapeutic value of Positional Therapy for severe Non Positional Patients (NPP)
Time Frame: From the beginning until December 2018
Positional therapy is an optimal therapeutic mode for PP but since the severity of apneas/hypopneas is worst in the supine than in the lateral posture, NPP could also obtain some benefits of this therapy we will assess the value of this possible benefit.
From the beginning until December 2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arie Oksenberg, PhD, Loewenstein Hospital - Rehabilitation Center, Raanana, Israel
  • Principal Investigator: Juha Töyräs, PhD, University of Eastern Finland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2018

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

December 1, 2020

Study Registration Dates

First Submitted

July 25, 2017

First Submitted That Met QC Criteria

July 25, 2017

First Posted (Actual)

July 28, 2017

Study Record Updates

Last Update Posted (Actual)

February 28, 2019

Last Update Submitted That Met QC Criteria

February 26, 2019

Last Verified

February 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

not relevant at this moment

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

3
Subscribe